2. Academic Validation
  3. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection

Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection

  • Clin Infect Dis. 2022 Aug 15;75(Supplement_1):S130-S135. doi: 10.1093/cid/ciac373.
Oludare A Odumade 1 2 3,  Simon D van Haren 1 2,  Asimenia Angelidou 1 2 4
Affiliations

Affiliations

  • 1 Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
  • 2 Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • 3 Department of Pediatrics, Division of Medicine Critical Care, Boston Children's Hospital, Boston, Massachusetts, USA.
  • 4 Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
PMID: 35579506 DOI: 10.1093/cid/ciac373
Abstract

Respiratory viral infections account for a large percentage of global disease and death. Respiratory syncytial virus is a seasonal virus affecting immunologically vulnerable populations, such as preterm newborns and young infants; however, its epidemiology has changed drastically during the coronavirus disease 2019 pandemic. In this perspective, we discuss the implications of coronavirus disease 2019 on respiratory syncytial virus seasonality patterns and mitigation efforts, as well as the urgent need for vaccination as a preventive tool.

Keywords

COVID-19; epidemiology; respiratory syncytial virus (RSV); vaccine.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P99804
    99.62%, Anti-RSV F Monoclonal Antibody
    RSV